CIRCULATING LEVELS OF CELL ADHESION MOLECULES IN HYPERTENSION

被引:0
作者
Shalia, Kavita K. [1 ]
Mashru, Manoj R. [2 ]
Vasvani, Jagdish B. [2 ]
Mokal, Rajashree A. [1 ]
Mithbawkar, Shilpa M. [1 ]
Thakur, Priti K. [1 ]
机构
[1] Sir HN Hosp & Res Ctr, Sir HN Med Res Soc, Raja Rammohan Roy Rd, Mumbai 400004, Maharashtra, India
[2] Sir HN Hosp & Res Ctr, Mumbai 400004, Maharashtra, India
关键词
Hypertension; Cell adhesion molecules; Selectins; ICAM-1; VCAM-1; PECAM-1;
D O I
10.1007/s12291-009-0070-6
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Hypertension causes complications such as coronary atherosclerosis and thrombosis wherein inflammatory factors play significant role. In the present study inflammatory molecules such as cell adhesion molecules (CAMs); endothelial (E)-selectin, platelet (P)-selectin, intercellular CAM-1 (ICAM-1), vascular CAM-1 (VCAM-1) and platelet endothelial CAM-1 (PECAM-1) were analysed in subjects newly diagnosed with hypertension with no secondary cause against normotensive healthy individuals. In each group 57 subjects were recruited and soluble (s) levels of CAMs were analysed by ELISA. As compared to controls median of sE-selectin (49.2%, P=0.001), sP-selectin (54.3%, P=0.001), and sICAM-1 (18.9%, P=0.012) were significantly elevated in hypertensive subjects. Significant negative correlation was observed of sP-selectin (spearman rank correlation coefficient (rs)=-0.345, p=0.027) and sPECAM-1 (rs=-0.446, p=0.003) with age in hypertension group. Hypertension may increase expression of certain CAMs while younger hypertensives in addition are also at increased risk of atherothrombosis.
引用
收藏
页码:388 / 397
页数:10
相关论文
共 52 条
  • [2] Is C-reactive protein an independent risk factor for essential hypertension?
    Bautista, LE
    López-Jaramillo, P
    Vera, LM
    Casas, JP
    Otero, AP
    Guaracao, AI
    [J]. JOURNAL OF HYPERTENSION, 2001, 19 (05) : 857 - 861
  • [3] Cold pressor test raises serum concentrations of ICAM-1, VCAM-1, and E-selectin in normotensive and hypertensive patients
    Buemi, M
    Allegra, A
    Aloisi, C
    Corica, F
    Alonci, A
    Ruello, A
    Montalto, G
    Frisina, N
    [J]. HYPERTENSION, 1997, 30 (04) : 845 - 847
  • [4] Effects of nebivolol on platelet activation in hypertensive patients: A comparative study with metoprolol
    Celik, Turgay
    Yuksel, U. Cagdas
    Iyisoy, Atila
    Kursaklioglu, Hurkan
    Ozcan, Omer
    Kilic, Selim
    Ozmen, Namik
    Isik, Ersoy
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2007, 116 (02) : 206 - 211
  • [5] C-reactive protein, insulin resistance, central obesity, and coronary heart disease risk in Indian Asians from the United Kingdom compared with European whites
    Chambers, JC
    Eda, S
    Bassett, P
    Karim, Y
    Thompson, SG
    Gallimore, JR
    Pepys, MB
    Kooner, JS
    [J]. CIRCULATION, 2001, 104 (02) : 145 - 150
  • [6] Elevated plasma high-sensitivity C-reactive protein concentrations in Asian Indians living in the United States
    Chandalia, M
    Cabo-Chan, AV
    Devaraj, S
    Jialal, I
    Grundy, SM
    Abate, N
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (08) : 3773 - 3776
  • [7] Exacerbation of atherosclerosis by hypertension - Potential mechanisms and clinical implications
    Chobanian, AV
    Alexander, RW
    [J]. ARCHIVES OF INTERNAL MEDICINE, 1996, 156 (17) : 1952 - 1956
  • [8] Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
    Cleeman, JI
    Grundy, SM
    Becker, D
    Clark, LT
    Cooper, RS
    Denke, MA
    Howard, WJ
    Hunninghake, DB
    Illingworth, DR
    Luepker, RV
    McBride, P
    McKenney, JM
    Pasternak, RC
    Stone, NJ
    Van Horn, L
    Brewer, HB
    Ernst, ND
    Gordon, D
    Levy, D
    Rifkind, B
    Rossouw, JE
    Savage, P
    Haffner, SM
    Orloff, DG
    Proschan, MA
    Schwartz, JS
    Sempos, CT
    Shero, ST
    Murray, EZ
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19): : 2486 - 2497
  • [9] Effect of valsartan compared with valsartan/hydrochlorothiazide on plasma levels of cellular adhesion molecules: the Val-MARC trial
    Conen, D.
    Everett, B. M.
    Glynn, R. J.
    Ridker, P. M.
    [J]. HEART, 2008, 94 (03) : e13
  • [10] Cottone S, 2002, J NEPHROL, V15, P643